Biotechnology

Innovative €250,000 Parenteral Nutrition Research Grant Awarded by Fresenius Kabi

BAD HOMBURG, Germany, Nov. 25, 2021 /PRNewswire/ -- Fresenius Kabi was delighted to announce the winner of their innovative JUMPstart education program and research grant onSeptember 10, 2021. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through th...

2021-11-25 15:45 2597

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2022

Added 19,066 New Subscribers in 2Q22 Revenues Up 9.8% YoY to RMB313.7 Million ($48.7 Million)         Gross Profit Up 11.0% YoY to RMB267.5 Million ($41.5 Million) Operating Income Up 15.3% YoY to RMB160.5 Million ($24.9 Million) Non-GAAP Operating Income Up 14.1% YoY to RMB172.8 Million ($26.8 Mi...

2021-11-25 05:16 3707

Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients

SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of p...

2021-11-24 23:14 2300

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

GAITHERSBURG, Md., Nov. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced its submission to the Singapore Health Sciences Authority (HSA) for interim ...

2021-11-24 22:15 2360

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biol...

2021-11-24 20:00 1686

Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round

BOSTON, Nov. 24, 2021 /PRNewswire/ -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced the completion of$40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capit...

2021-11-24 16:11 1566

Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index

SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...

2021-11-24 08:00 1810

Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index

SHANGHAI, Nov. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...

2021-11-24 08:00 2222

Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan

SUZHOU, China and PALO ALTO, Calif., Nov. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...

2021-11-23 22:00 2298

Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies

SAN DIEGO, Nov. 23, 2021 /PRNewswire/ -- Neurophth Therapeutics Ltd., ("Neurophth"), a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, today announced the closing of over$60 million USD in Series-C financing with a...

2021-11-23 21:30 1404

Brain Navi NaoTrac, the Brain Surgical Navigation Robot, Received European CE Mark Approval in 2021

ZHUBEI CITY, Taiwan, Nov. 23, 2021 /PRNewswire/ -- Brain Navi Biotechnology, a Taiwan-based startup specializing in innovative navigation robots, received CE mark approval for brain surgery procedures in Q1 2021 for its NaoTrac, a robotic-assisted surgical robot. As the next step Brain Navi Bi...

2021-11-23 21:10 1854

Inaugural Asia Summit on Global Health held 24 November in hybrid format in Hong Kong

HONG KONG, Nov. 23, 2021 /PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) will take place on24 November 2021 at the Hong Kong Convention and ...

2021-11-23 19:40 1634

Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States

ADELAIDE, Australia, Nov. 23, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the public filing of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") in...

2021-11-23 19:37 2356

Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum

* Q3 Revenue held steady at KRW 305.3 billion * Operating profit dipped slight due to powerful investment in R&D * Scheduled to introduce new diagnostic tests capable of screening 22 targets, including3 genes of COVID-19 and 19 respiratory viruses in a single tube  SEOUL, South Korea, Nov. 2...

2021-11-23 16:03 1588

PromarkerD distribution network expands to Britain

* World's first predictive diagnostic test for diabetic kidney disease to be sold inGreat Britain under distribution deal with global diagnostic distributor, Apacor Limited * Apacor will become the exclusive distributor for PromarkerD in Great Britain (England, Scotland and Wales) * Estimat...

2021-11-23 11:56 1617

Gilead Sciences, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), and the World Hepatitis Alliance (WHA) Collaborate to Support Elimination of Hepatitis by 2030

* Today, an Estimated 257 Million People Live With Hepatitis B Globally. The World Health Organization Has Categorized Viral Hepatitis as a Public Health Threat and Has Set Targets for Elimination by 2030. * Despite National Immunization Programs Being Implemented in the 1980s, More Than 50% ...

2021-11-23 11:00 1411

EZZ accelerates genomic health focus with launch of two new biotic products

SYDNEY, Nov. 23, 2021 /PRNewswire/ -- EZZ Life Science Holdings Limited (ASX: EZZ),an Australian genomic life science company with a mission to improve quality of life and human health, is pleased to have added two new consumer health products to its range, to be sold in pharmacies acrossAustrali...

2021-11-23 04:00 1580

Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME)

* First-in-class SCS Microinjection therapy * First clinical registration study and potentially the first approved drug in China targeting macular edema associated with uveitis * U.S. FDA approved for treatment of macular edema associated with uveitis SHANGHAI, Nov. 22, 2021 /PRNewswire/ -- A...

2021-11-22 23:17 1350

Getinge accelerates growth and productivity to reach new financial targets

GOTHENBURG, Sweden, Nov. 22, 2021 /PRNewswire/ -- "Getinge's new financial targets for 2022-2025, an annual organic net sales growth of 4-6% and adjusted EPS growth of above 10% on average throughout the period, is well in line with our strategy and ambitions", says Mattias Perjos, President & CE...

2021-11-22 21:50 1395

Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia

SUZHOU, China, and ROCKVILLE, MD., Nov. 22, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the European Commission (EC) has granted the...

2021-11-22 21:24 1628
1 ... 160161162163164165166 ... 275

Week's Top Stories